VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 17 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $371 | -25.9% | 464 | 0.0% | 0.00% | – |
Q2 2023 | $501 | +37.6% | 464 | 0.0% | 0.00% | – |
Q1 2023 | $364 | +26.0% | 464 | 0.0% | 0.00% | – |
Q4 2022 | $289 | -71.1% | 464 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 464 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 464 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 464 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | – | 464 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 988,165 | $614,935 | 0.54% |
Quantum Private Wealth, LLC | 10,000 | $6,223 | 0.00% |
Warberg Asset Management LLC | 17,012 | $10,561 | 0.00% |
Belpointe Asset Management LLC | 19,045 | $11,852 | 0.00% |
OSAIC HOLDINGS, INC. | 600 | $0 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $62,744 | 0.00% |
WELLS FARGO & COMPANY/MN | 59 | $37 | 0.00% |
NORTHERN TRUST CORP | 15,221 | $9,472 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 66,038 | $41 | 0.00% |